EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS113-19340 
Organism
Homo sapiens 
Tissue/cell
Keratinocyte 
Coordinate
chr2:55172270-55174150 
Target genes
Number: 10             
NameEnsembl ID
TF binding sites/motifs
Number: 22             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ZNF263MA0528.1chr2:55172361-55172382CCTCCCCCTTCTCTCTCCCCT-6.03
ZNF263MA0528.1chr2:55172391-55172412CCTCCCCCTTCTCTCTCCCCT-6.03
ZNF263MA0528.1chr2:55172421-55172442CCTCCCCCTTCTCTCTCCCCT-6.03
ZNF263MA0528.1chr2:55173338-55173359CCCCCCTGCCCATTCTCCTCA-6.13
ZNF263MA0528.1chr2:55172858-55172879TGGGGAGGGGGAAAGGAGGGA+6.26
ZNF263MA0528.1chr2:55172374-55172395TCTCCCCTCTCTCTCTCCCTC-6.42
ZNF263MA0528.1chr2:55172324-55172345TCTCTCCCCTCCCCCTTCTCT-6.43
ZNF263MA0528.1chr2:55172354-55172375CTCTCTCCCTCCCCCTTCTCT-6.52
ZNF263MA0528.1chr2:55172384-55172405CTCTCTCCCTCCCCCTTCTCT-6.52
ZNF263MA0528.1chr2:55172280-55172301ATCCCTCCCTACCCCTCCTCC-6.55
ZNF263MA0528.1chr2:55172304-55172325TCCCCTCTTTCCCCCTCCCCT-6.66
ZNF263MA0528.1chr2:55172344-55172365TCTCCCTTCTCTCTCTCCCTC-6.68
ZNF263MA0528.1chr2:55172298-55172319TCCCCCTCCCCTCTTTCCCCC-6.81
ZNF263MA0528.1chr2:55172289-55172310TACCCCTCCTCCCCCTCCCCT-6.86
ZNF263MA0528.1chr2:55172408-55172429CCCTCTCTCTCTGCCTCCCCC-6.89
ZNF263MA0528.1chr2:55172432-55172453TCTCTCCCCTCCCCCTCCCCT-7.02
ZNF263MA0528.1chr2:55172313-55172334TCCCCCTCCCCTCTCTCCCCT-7.04
ZNF263MA0528.1chr2:55172283-55172304CCTCCCTACCCCTCCTCCCCC-7.39
ZNF263MA0528.1chr2:55172426-55172447CCCTTCTCTCTCCCCTCCCCC-7.55
ZNF263MA0528.1chr2:55172348-55172369CCTTCTCTCTCTCCCTCCCCC-7.57
ZNF263MA0528.1chr2:55172318-55172339CTCCCCTCTCTCCCCTCCCCC-7.59
ZNF263MA0528.1chr2:55172378-55172399CCCTCTCTCTCTCCCTCCCCC-7.91
Number of super-enhancer constituents: 3             
IDCoordinateTissue/cell
SE_04637chr2:55172259-55176139Brain_Anterior_Caudate
SE_08302chr2:55172204-55176450Brain_Inferior_Temporal_Lobe
SE_30539chr2:55172396-55173971Fetal_Muscle
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr25517260055173172
chr25517231955173554
Number: 1             
IDChromosomeStartEnd
GH02I054945chr25517239855173977
Enhancer Sequence
TCCCTCCCTC ATCCCTCCCT ACCCCTCCTC CCCCTCCCCT CTTTCCCCCT CCCCTCTCTC 60
CCCTCCCCCT TCTCTCTCCC TTCTCTCTCT CCCTCCCCCT TCTCTCTCCC CTCTCTCTCT 120
CCCTCCCCCT TCTCTCTCCC CTCTCTCTCT GCCTCCCCCT TCTCTCTCCC CTCCCCCTCC 180
CCTTTGGATT TCCCAAGACA TTCTAAAACC ATTGGAGCAT TTTATGCCAC ATTTTGGAAG 240
CTGAAGAAAG CTGTTTCCTC CAAGGACACT TTGAACATTG TCTGATGAAC ACGACTCAAA 300
ACAACTTCAA ACTTGAATTT CTTGGCTAGT TGGAACTGAG TTTCCCCACA CTCACACCCA 360
CACCCACACC CCTCTTTATA GAAACTGGTT GGAACGACTT GGTTTCTCAC AGGCTGTCCA 420
AGCCTCACTC CCCAGTTGGC TCTCATGTTG TACTCATCTT GGGTTGCAAC TGACTCGTGA 480
CCTCAGTGGT TTCAGAAGCT TCCCTGAGCA CTTTGGCCCT GAATGCTCTT ACACATTTCA 540
GGTCATTGTG TGCTCTGCTC CACCTCTTGC TCTGTCAGCC CAGTGCCTTG GGGAGGGGGA 600
AAGGAGGGAC AAGTACCCAG GCATTGGCCT GCCTTGCGGG TCTGTGCAGG GCAAGAGCCC 660
GTGTCAGGAT AAGACTCCCC ACATCTTTAG TTGAGTCTAA GCTTTCTCTT CAGCAGCCCA 720
GCGCTGGGCA GTGGGATGAC AGCAGGAATT GGCCTTCCCA TGATCCTGCC CTGCCCACAG 780
AATGTGCCAA CTGTTTCCAC AGGGGGTACA GGGTTGTGAC TCTCCCCACA GGCACTGAAG 840
AGCAGGGCCG ACTTGTTACT CAACACCAAG CCCCAGGCTG GAGTTCACAG CCTCTCCCTG 900
GGCTTCCTGC CTTCACTCTG TCTTCTTGGC AGGCTTCTCC TGCTCTCCAG AGCTTCGGCC 960
TGTGTGCCAC CCTCTCTCCT GATTATCCAG TTTGTTTGCT GTCTTGCCAG GCTCCCTCCT 1020
TAAATTTCTT GCCAATGGAA GCTCTTTCTC CTTTGTTCCC TGACCCTGCC CCCCTGCCCA 1080
TTCTCCTCAA AGCCTACTTG CCCCACCAGG CCCCTTTGTG TCTCTGCTCC TCCCACCTCC 1140
AGTCTCTCAC CCCCTCACCT TCCCAGATCT TGGCCCCACT GGGTCTCCCT GCCAATGCCG 1200
GGTTGTGCCC ACAGCCTTCC TCGCACTCCT GTCCTGTGCC AGCTGGGAAT GACCAACTCT 1260
AATGAGCTGA TTGGACTGAA AGTGAGTGAA TGTCCTCATG CCTCCACTCC TTCCCACCTC 1320
AGCAAAGCTT TTCAGAGTCC CATTTCTGAT GGAATCTGAA TCTAGAAGGA TTTAGATCCA 1380
CGGAAAACTG TTAAACCTCC AGTGTTTGGC TACGTGTGAA GTCTCTGGCA GTCCCTCCCA 1440
CATCTGATGT TATGAACACT GTTTATAGAT GCCTGGAAAG AAGCTTTTAA TACTTGTATT 1500
GTGTTTTAAC TTGCTTTCCT TTGGAGGCAG GGAATTGTCA AGTAAGTATT CACACCGCTC 1560
TGGAGACAAA CACAGGTGTT TGGTGAACAT CCAGTACTAA GTGTTCACGC AGAATCCACA 1620
ACCGCGAAGG GTCAATACTT AAAATCCGCT GAATTTGCCA CAATGCAGGT TTCTTCCCCT 1680
TGCTCCTCTC ATCTTCAGTT TTGAAGCAAT ACAGCTGTAA ACATATGCTT GCGAAATGAG 1740
AAAGAAACAT TGAGATTGCT TTACCTTTCG GTTTTTTTCT GAAAATCAAG GTGAAAAAAA 1800
AAAGCATCGG ATTGCGTCTG TGTATATATA TACAATCTCC TGTATATATA AATACACGGT 1860
GTTTGTGCTT GTACGCATAC 1880